Skip to content
Contact About us Swedish residents

Karolinska first in the Nordics with new program for advanced liver treatment ahead of transplantation

NEWS
Published
Innovation
Specialized healthcare
Future of healthcare
More patients may now get a new chance at life as Karolinska University Hospital becomes the first hospital in the Nordics to introduce a new method for liver transplantation. The method makes it possible to keep a liver alive outside the body for up to 24 hours – allowing more organs to be used, operations to be planned with greater safety, and more patients to access life-saving treatment.
A man in a blue sweater standing in front of a poster.
Gabriel Oniscu. Photo: Sanne Jonsson

Karolinska University Hospital is the first hospital in the Nordics to launch a program for so-called ex vivo normothermic liver perfusion. This method keeps the liver alive and perfused in a machine outside the body, enabling organs to be preserved for longer periods while also allowing their function to be assessed prior to transplantation.

The new technology represents several important advances for transplantation care:

  • More organs can be used. Organs previously deemed uncertain can be evaluated and, in many cases, approved for transplantation.
  • Longer preservation time. Organs can be kept alive for up to 24 hours, reducing the need for emergency night-time surgeries, improving planning for complex transplant operations, and enhancing access to transplantation for patients.
  • Better working environment. Surgeries can increasingly be scheduled during daytime hours, contributing to improved working conditions and more sustainable staff scheduling.
  • Increased patient benefit. With more organs available for transplantation, the chances of saving lives increase.

This places Karolinska University Hospital among the leading transplantation centers in Europe. During the first two weeks of the program, five successful procedures were carried out, with machine preservation times of up to 20 hours – the first of their kind in the Nordics.

“This is a decisive step forward in the development of liver transplantation. With machine perfusion, we can both evaluate and improve organs before they are transplanted. This means that more patients will have access to life-saving treatment, while we also make better use of all available organs,” says Professor Gabriel Oniscu, senior consultant and program lead at Karolinska University Hospital.

“The introduction of this technology at Karolinska is an important milestone for both patients and staff. It enables safer planning of surgeries and contributes to a more sustainable working environment, while reinforcing the hospital’s role as one of Europe’s foremost transplantation centers,” says Alberto Falk-Delgado, Acting Manager Emergency and Reparative Medicine Theme at Karolinska University Hospital.

The program has been made possible thanks to close collaboration between transplant surgeons, operating room and anesthesia staff, perfusionists, coordinators, as well as support from research and development units, hospital management, and regional partners.

Text: Marcus Hagström

Normothermic means that the organ is preserved fully functioning at body temperature. During machine perfusion, blood is pumped through the liver, allowing oxygen, nutrients, and medicines to be delivered.
The method makes it possible to test liver function before transplantation.
In recent years, the technology has been introduced at leading centers in Europe and North America.

Last updated:

Similar news

Published
At Karolinska University Hospital, precision medicine is proving to be a valuable tool in cancer diagnostics. "Through more comprehensive genomic analysis of cancer cells, we can gain a better understanding of the specific genetic abnormalities in each ind...
Published
On 4 November, Knut Steffensen will be taking up office as the director of the Karolinska ATMP Centre, a leading centre for advanced therapy medicinal products, with research, manufacture and treatment all under one roof.